Crystal structure of the anthrax lethal factor
- PMID: 11700563
- DOI: 10.1038/n35101998
Crystal structure of the anthrax lethal factor
Abstract
Lethal factor (LF) is a protein (relative molecular mass 90,000) that is critical in the pathogenesis of anthrax. It is a highly specific protease that cleaves members of the mitogen-activated protein kinase kinase (MAPKK) family near to their amino termini, leading to the inhibition of one or more signalling pathways. Here we describe the crystal structure of LF and its complex with the N terminus of MAPKK-2. LF comprises four domains: domain I binds the membrane-translocating component of anthrax toxin, the protective antigen (PA); domains II, III and IV together create a long deep groove that holds the 16-residue N-terminal tail of MAPKK-2 before cleavage. Domain II resembles the ADP-ribosylating toxin from Bacillus cereus, but the active site has been mutated and recruited to augment substrate recognition. Domain III is inserted into domain II, and seems to have arisen from a repeated duplication of a structural element of domain II. Domain IV is distantly related to the zinc metalloprotease family, and contains the catalytic centre; it also resembles domain I. The structure thus reveals a protein that has evolved through a process of gene duplication, mutation and fusion, into an enzyme with high and unusual specificity.
Comment in
-
Tackling anthrax.Nature. 2001 Nov 8;414(6860):160-1. doi: 10.1038/35102660. Nature. 2001. PMID: 11700539 No abstract available.
Similar articles
-
The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.Mol Aspects Med. 2009 Dec;30(6):431-8. doi: 10.1016/j.mam.2009.07.006. Epub 2009 Aug 7. Mol Aspects Med. 2009. PMID: 19665472 Review.
-
Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.Proteins. 2009 May 1;75(2):323-35. doi: 10.1002/prot.22241. Proteins. 2009. PMID: 18831046
-
Crystal structure of the anthrax toxin protective antigen.Nature. 1997 Feb 27;385(6619):833-8. doi: 10.1038/385833a0. Nature. 1997. PMID: 9039918
-
Identification of the cellular receptor for anthrax toxin.Nature. 2001 Nov 8;414(6860):225-9. doi: 10.1038/n35101999. Nature. 2001. PMID: 11700562
-
Anthrax toxins.Rev Physiol Biochem Pharmacol. 2004;152:135-64. doi: 10.1007/s10254-004-0028-2. Epub 2004 Jul 27. Rev Physiol Biochem Pharmacol. 2004. PMID: 15549606 Review.
Cited by
-
Probing Translocation in Mutants of the Anthrax Channel: Atomically Detailed Simulations with Milestoning.J Phys Chem B. 2018 Nov 15;122(45):10296-10305. doi: 10.1021/acs.jpcb.8b08304. Epub 2018 Nov 5. J Phys Chem B. 2018. PMID: 30338689 Free PMC article.
-
Protein translocation through anthrax toxin channels formed in planar lipid bilayers.Biophys J. 2004 Dec;87(6):3842-9. doi: 10.1529/biophysj.104.050864. Epub 2004 Sep 17. Biophys J. 2004. PMID: 15377524 Free PMC article.
-
Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.EMBO J. 2005 Mar 9;24(5):929-41. doi: 10.1038/sj.emboj.7600574. Epub 2005 Feb 17. EMBO J. 2005. PMID: 15719022 Free PMC article.
-
Monitoring the kinetics of the pH-driven transition of the anthrax toxin prepore to the pore by biolayer interferometry and surface plasmon resonance.Biochemistry. 2013 Sep 17;52(37):6335-47. doi: 10.1021/bi400705n. Epub 2013 Sep 9. Biochemistry. 2013. PMID: 23964683 Free PMC article.
-
Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells.PLoS One. 2011;6(8):e23133. doi: 10.1371/journal.pone.0023133. Epub 2011 Aug 5. PLoS One. 2011. PMID: 21850257 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases